Overview

Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
Prospective randomized, placebo controlled, clinical trial to evaluate the effect of human growth hormone supplementation compared with placebo to patients with severe heart failure for a duration of 6 months on exercise capacity, heart function and quality of life
Phase:
Phase 2
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Treatments:
Hormones